{"article_title": "Morning Read: Roche acquires microbiology diagnostics", "article_keywords": ["upper", "users", "read", "university", "million", "microbiology", "arm", "morning", "roche", "health", "tumors", "diagnostics", "implanted", "sensor", "centers", "acquires"], "article_url": "http://medcitynews.com/2015/08/roche/", "article_text": "TOP STORIES\n\nRoche has acquired in vitro diagnostics group GeneWEAVE BioSciences in a $425 million deal. It uses \u201csmarticles technology\u201d \u2014 molecular diagnostics that identify multidrug-resistant organisms and assess antibiotic susceptibility from clinical samples. \u2014 PharmaTimes\n\nLIFE SCIENCES\n\nResearchers have found that schizophrenia is linked with significant changes in connections between the thalamus and the frontal cortex. The identified markers are visible before schizophrenia fully develops, which indicates that the connection changes aren\u2019t developed as a result of the disease or medications, but are a precursor. \u2014 Drugs.com\n\nLiquid biopsy player Biocept announced that its teaming up with the University of California, Irvine, to evaluate blood-based biomarkers in patients with metastatic cancers. \u2014 Fierce Diagnostics\n\nWhich one is more powerful: the FDA or the First Amendment? \u2014 The Incidental Economist blog\n\nPAYERS-PROVIDERS\n\nHHS announced that it will spend $169 million to open 266 new health center sites across the nation with funding from the Affordable Care Act.\n\nThe new health centers will be located in 46 states, Washington, D.C., and Puerto Rico and are projected to increase access to healthcare services for more than 1.2 million patients. The investment in the centers will add to the more than 700 new health centers that have opened as a result of the ACA, according to HHS. \u2014 Becker\u2019s Hospital CFO\n\nTECH\n\nGlucose monitor device maker Senseonics raised $10 million implanted smartphone-connected sensor.\n\nSenseonics\u2019 pill-like sensor is entirely implanted in the user\u2019s upper arm so that it can continuously monitor the user\u2019s glucose levels. The device is meant to last at least 90 days before it needs to be replaced. The sensor sends data to a transmitter that a users wears on their upper arm as well. When on the user\u2019s upper arm, the transmitter can take readings from the implanted sensor and send them to a companion smartphone app. \u2014 MobiHealth News\n\nPOLITICS\n\nA New England Journal of Medicine editorial responds to the Republican-driven controversy over Planned Parenthood and fetal tissue research. \u2014 New England Journal of Medicine\n\nA National Institutes of Health-funded study involving researchers at Case Western Reserve University found they could detect fast-growing cancerous tumors using an MRI and a special contrast solution.\n\n\u201cWe showed with this technique that we can detect very tiny tumors of just a few hundred cells,\u201d Zheng-Rong Lu, who led the study, said. The technique could \u201cpotentially can make a big impact on clinical practice and also management of cancer.\u201d \u2014 The Hill\n\nA LITTLE BIT EXTRA\n\nLG Display continues to be the leading pioneer in flexible technology, and it just debuted its new flexible TV panel at an event in Korea. Pretty cool stuff.\n\n\u2014 IFLScience\n\nPhoto: Roche", "article_metadata": {"description": "Roche has acquired in vitro diagnostics group GeneWEAVE BioSciences in a $425 million deal.", "generator": "WordPress 4.5.2", "og": {"site_name": "MedCity News", "description": "Roche has acquired in vitro diagnostics group GeneWEAVE BioSciences in a $425 million deal.", "title": "Morning Read: Roche acquires microbiology diagnostics", "locale": "en_US", "image": "http://medcitynews.com/wp-content/uploads/2015/08/roche.jpg", "updated_time": "2015-10-02T11:54:28-04:00", "url": "http://medcitynews.com/2015/08/roche/", "type": "article"}, "twitter": {"image": "http://medcitynews.com/wp-content/uploads/2015/08/roche.jpg", "description": "Roche has acquired in vitro diagnostics group GeneWEAVE BioSciences in a $425 million deal.", "card": "summary", "title": "Morning Read: Roche acquires microbiology diagnostics - MedCity News"}, "robots": "noodp", "fb": {"app_id": 148725768475669}, "google-site-verification": "xudQg7nxVR9ifmMTY4Tf-0wVtX9b6rWLQd0utCweGOc", "keywords": "weight loss, obesity, overweight,diabetes,massachusetts,medical devices,obesity,startups,healthcare innovation, medcity news,medcity news,san francisco, startups, life sciences,accelerator,rock health,startup advice,startup funding,patient monitoring system, motion sensors ,dc,healthcare it,washington,foodborne pathogens, diagnostics company, diagnostic platforms,minimally invasive surgery, laser surgery,cambridge,dealflow,hospitals,wellpoint, healthways, health and wellness, employee wellness programs,investing,wellness,medtronic, shanghai innovation center, china, r&d,china,mdt,minneapolis,minnesota,publics,twin cities,ulcerative colitis, abbott labs, humira,abbott labs,doctors,pharmaceuticals,skin disorders, pharmaceuticals, md anderson cancer center,cancer,texas,renal denervation, st. jude medical,st. jude medical,stj,emr, ehr, electronic health records, electronic medical records, certified emr,certified emr,ehr,electronic health records,electronic medical records,advanced cellular technology,amyotrophic lateral sclerosis,embryonic stem cells,geron corporation,lou gehrig\\'s disease,macular degeneration,regenerative medicine,spinal cord damage,value-based healthcare system, obamacare, fee-for-service model,california,cleveland,health insurance,insurance,ohio,pennsylvania,politics,cancer treatment options library, aetna, aet, healthcare it,aet,aetna,health it,phi,philadelphia,Diagnostics, GeneWEAVE BioSciences, morning read, Roche, , MedCity News", "article": {"section": "Daily", "tag": "Roche", "published_time": "2015-08-13T07:55:43-04:00", "modified_time": "2015-10-02T11:54:28-04:00"}, "viewport": "width=device-width,initial-scale=1.0,width=device-width,user-scalable=no,minimum-scale=1.0,maximum-scale=1.0"}, "_id": "\"57477af46914bd0286fe00a5\"", "article_summary": "When on the user\u2019s upper arm, the transmitter can take readings from the implanted sensor and send them to a companion smartphone app.\nSenseonics\u2019 pill-like sensor is entirely implanted in the user\u2019s upper arm so that it can continuously monitor the user\u2019s glucose levels.\nThe investment in the centers will add to the more than 700 new health centers that have opened as a result of the ACA, according to HHS.\n\u2014 Becker\u2019s Hospital CFOTECHGlucose monitor device maker Senseonics raised $10 million implanted smartphone-connected sensor.\nThe sensor sends data to a transmitter that a users wears on their upper arm as well."}